United States Augmented Reality in Healthcare Market Assessment, By Component, By Product, By Device Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

United States augmented reality in healthcare market is projected to witness a CAGR of 24.48% during the forecast period 2024-2031, growing from USD 1373.12 million in 2023 to USD 7916.93 million in 2031. The market's growth is supported by the acceptance of new technologies in the country, rapid adoption of augmented reality (AR) in medical schools, increasing utilization of AR for medical training, rising research and development activities, and novel launches. In January 2023, Galderma S.A. announced the launch of FACE, an AR solution that aids healthcare professionals to improve patient satisfaction. The solution enables practitioners to evaluate the whole face in real-time, allowing for an interactive and immersive consultation process. The technology became available in the United States in the first half of 2023.

The potential of AR to transform healthcare and ensure the delivery of new diagnostic and treatment solutions is altering the way in which care is delivered. The growing awareness about the different advantages associated with AR is also bolstering the demand for augmented reality in the healthcare market in the United States. AR improves patient accessibility to healthcare and the abilities of healthcare professionals to prepare for different treatments, mitigates preoperative anxiety, accelerates diagnosis, and decreases the invasiveness of procedures.

Adoption by Medical Schools Boosts Market Demand

Various medical schools across the country are increasingly using augmented reality for real-time data visualization during surgeries. Biomedical engineers and doctors at Stanford Medicine are among the first to integrate novel AR tools into surgical practice. The headset provides human-computer interaction, allowing the wearer to navigate their surroundings with the help of virtual elements in combination with real-time visual data. The use of AR in the operating room exemplifies Stanford's mission of serving patients in a human-centered and digitally driven care environment. With the first demonstration, the medical school aims to establish the AR tool as something proceduralists and surgeons can use to manipulate and review intraprocedural data, reduce barriers, and boost efficiency.

Introduction of Novel Technologies Strengthens Market Expansion

The increasing efforts of the leading medical technology companies and market players to boost the introduction of novel technologies and equipment in the country are providing lucrative growth opportunities. In July 2024, Immersive Touch Inc. announced that ImmersiveAR, their groundbreaking augmented reality technology platform, received 510(k) clearance from the United States Food and Drug Administration (US FDA) for clinical usage in operating rooms. The company plans to immediately commence the commercialization of the platform in the country, which improves craniomaxillofacial (CMF) surgeries by allowing the reduction of pre-operative planning workflow to minutes. The surgeons can also simulate surgical changes to bones, tailoring the procedure to the unique anatomy of the patient, thereby reducing complications and errors. Such accretive solutions for hospitals can aid in lowering healthcare costs and generate additional reimbursement for payors.

Medical Trainings Hold Significant Market Share

The increasing emphasis towards the deployment of AR technology for training surgeons and other healthcare professionals is supporting the United States augmented reality in healthcare market growth. Implementing AR in medical training for superimposing digital reconstruction of an anatomical structure provides a holistic understanding of different biological systems. Furthermore, the interaction of medical students with AR overlays improves the learning process, making it more hands-on and engaging. Due to such advantages, various market players are collaborating with different training centers to elevate medical training. In June 2024, Stryker Corporation announced a multi-year agreement with IRCAD North America to support the creation of a cutting-edge educational center in North Carolina, United States. The company will provide IRCAD with advanced medical devices to elevate the skills of technicians and physicians. The center will focus on surgical artificial intelligence, medical virtual and augmented reality, simulation training, and robotics. Such collaborations support the creation of unique training environments that allow for the advancement of medicine and improved patient outcomes.

Hospitals and Clinics Account for Major Market Share

The segment's growth can be attributed to the increasing introduction of different AR technologies in hospitals and clinics across the country. In January 2024, AdventHealth Hospital successfully completed a cranial vault remodeling for craniosynostosis with the help of a VisAR augmented reality surgical navigation system. The surgery showcased the utilization of AR as a guide during complex surgeries. With AR technology's help, surgeons can navigate complex correctional cuts, simplifying the surgery. Real-time superimposition in the 3D space of the patients has been used in a wide range of surgical disciplines, including plastic surgery, interventional radiology, spine surgery, orthopedic surgery, and neurosurgery. The introduction of such technologies in hospitals and clinics is expected to enhance surgeon convenience and support the growth of the United States augmented reality in healthcare market.

Future Market Scenario (2024-2031F)

As per the United States augmented reality in healthcare market analysis, the rising cases of chronic diseases and increasing investments by market players towards introducing novel technologies and systems are expected to provide lucrative growth opportunities. The National Cancer Institute estimates that approximately 2,001,140 new cancer cases are expected to be diagnosed in 2024 in the United States. AR is expected to play a significant role in helping surgeons locate tumors and imaging tumors during chemotherapy. AR imaging applications can also provide insights into the tumors' structure, size, and shape and allow the comparison of the tumor throughout the chemotherapy. AR is also expected to be significant in monitoring and treating various diseases and disorders in the coming years.

Key Players Landscape and Outlook

Novel launches by key players are expected to boost the United States augmented reality in healthcare market size. For instance, in June 2024, GE Healthcare Technologies, Inc. announced the deployment of their first AR system that provides 3D anatomy holograms during an image-guided, live procedure. Such developments are expected to allow the introduction of novel prospects in different treatments and enhance the convenience of healthcare professionals. The wearable heads-up display of the OmnifyXR system, provided by GE Healthcare, can show four different information feeds at the same time, including blood flow data, ultrasound imaging, and real-time X-ray fluoroscopy. The main goal of the system is to place important information within the line of sight of the surgeon, aiding them in focusing on the patients and allowing digital collaborations between clinicians, with remote first-person view.